The Nathan Shock Aging Center will build upon the recognized strengths in basic research in aging at San Antonio, e.g.: (1) the utilization of transgenic animals and dietary restriction to study of the mechanism(s) of aging at the molecular, cellular, and physiological levels, (2) the detailed characterization of survival and pathological lesions in aging rodents to determine the effect of aging, disease, and their interaction on biological processes, and (3) the large number of faculty at San Antonio who are actively involved in basic biological research in aging. The Center proposed in this application will consist of three Resource Cores, a Research Development Core, and a Program Enrichment Core. The Resource Cores will include a Transgenic Core, an Animal Core, and a Pathology Core. The central premise underlying the Nathan Shock Aging Center described in this proposal is that identifying the biological mechanisms leading to senescence can best be achieved by manipulating the whole organism genetically, nutritionally, or pharmacologically in ways that modify the aging process rather than by relying on phenomenological studies of the aging phenotype. The purpose of the Nathan Shock Aging Center is to combine this approach with our existing research strengths to enhance basic research on aging in five ways. First, the Center will facilitate genetic manipulations of animal models to test hypotheses relevant to senescence; services required to produce transgenic mice, transgenic rats, and transgenic mice with gene knockouts will ter investigators. Second, the Center will provide the resources and environment for the development of new genetic, nutritional, and pharmacological interventions in rodent models that are designed to modify the aging process(es). Animals from these interventions will then be supplied to Center investigators to test hypotheses concerning the mechanism(s) of mammalian aging. Third, the center will characterize the pathological status of all animal models developed in the Center. Fourth, the Center will promote novel approaches to the study of aging by providing funds for pilot projects. Fifth, the Center will have an administrative base designed to enhance collaborative research on aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG013319-03S1
Application #
2747430
Study Section
Special Emphasis Panel (ZAG1 (30))
Project Start
1995-07-10
Project End
2000-06-30
Budget Start
1998-04-01
Budget End
1998-06-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Kang, Donghoon; Kirienko, Daniel R; Webster, Phillip et al. (2018) Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence 9:804-817
Hook, Michael; Roy, Suheeta; Williams, Evan G et al. (2018) Genetic cartography of longevity in humans and mice: Current landscape and horizons. Biochim Biophys Acta Mol Basis Dis 1864:2718-2732
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918

Showing the most recent 10 out of 231 publications